-
ProductsOur company can produce anti-tumor, anti-fungal, antibiotics, nutrition, anesthesia, cardiovascular and cerebrovascular products such as 6 categories of series of products, the company's existing domestic products 73 product specifications and foreign products 22 product specifications.
-
NewsFrom 2019 to now, the company has attracted 38 kinds of generic drugs developed by 12 scientific research institutes such as Beijing Tongrentang Pharmaceutical Technology Development Co., Ltd. and Shanghai Rongdi Biotechnology Co., Ltd. to land in our company. After all of them are put into production, the annual output value can be increased by 1 billion and the profit can be about 0.2 billion.
Label Navigation
Nuocheng
Product Content
undefined
News Content
undefined
Hazardous waste pollution prevention and control of environmental information publicity
Shanxi Nuocheng Pharmaceutical Co., Ltd. 2022 Hazardous waste pollution prevention and control information public announcement
隐藏域元素占位
undefined
1. The test report is invalid without the "Special Seal for Inspection and Testing of Shanxi Huahanjing Environmental Testing Co., Ltd. 2. Without the written approval of the company, the test report shall not be partially copied, and shall not be used as evidence for arbitration or judicial appraisal. The copy report shall be invalid if it is not re-stamped with the "special seal for inspection and testing" of our unit or the official seal of the testing unit.
隐藏域元素占位
undefined
Self-monitoring programme in 2023
Geographical Location: Shanxi Nuocheng Pharmaceutical Co., Ltd. is located in the Medical Park of Huairen Economic and Technological Development Zone. Its geographical coordinates are 113.1033609 east longitude and 39.5036710 north latitude. Nuocheng Pharmaceutical Factory is 1.11km west of Xinfa Village and 0.7km east of E Mao River. The factory is surrounded by the main roads of the park, with convenient transportation.
隐藏域元素占位
undefined
According to the "Decision of the State Council on Amending the" Regulations on the Administration of Environmental Protection for the Completion of Construction Projects "(State Council Order No. 682), and the Ministry of Environmental Protection" On Issuing<建设项目竣工环境保护验收暂行办法>(National Environmental Regulations EIA [2017] No. 4), the "Shanxi Nuocheng Pharmaceutical Co., Ltd. reconstruction and expansion of the annual output of 2 x 63 tons of amino acid derivatives series, annual output of 2 x 4 tons of cimetidine bulk drug product production line project (phased) completion of the environmental protection acceptance monitoring report" for the full publication as follows:</建设项目竣工环境保护验收暂行办法>
隐藏域元素占位
undefined
According to the "Decision of the State Council on Amending the Regulations on the Administration of Environmental Protection of Construction Projects" (State Council Order No. 682), and the original Ministry of Environmental Protection "On Issuing<建设项目竣工环境保护验收暂行办法>(National Environmental Regulation EIA [2017] No. 4), Shanxi Nuocheng Pharmaceutical Co., Ltd. will now expand the annual output of 2 x 63 tons of amino acid derivatives series, annual output of 2 x 4 tons of cimetidine API product production line project environmental protection facilities commissioning date is announced as follows:</建设项目竣工环境保护验收暂行办法>
隐藏域元素占位
undefined
According to the "Decision of the State Council on Amending the Regulations on the Administration of Environmental Protection of Construction Projects" (State Council Order No. 682), and the original Ministry of Environmental Protection "On Issuing<建设项目竣工环境保护验收暂行办法>The announcement of the "(national environmental planning and environmental assessment [2017] No. 4) and the" technical specification for environmental protection acceptance of construction project completion "(HJ 792-2016), the completion date of environmental protection facilities of Shanxi nuocheng pharmaceutical co., ltd. for the project of rebuilding and expanding the production line of amino acid derivatives with an annual output of 2 × 63 tons and cimetidine bulk drug products with an annual output of 2 × 4 tons is hereby announced as follows:</建设项目竣工环境保护验收暂行办法>
隐藏域元素占位
Our company's key project in Shanxi Province in 2017-API synthesis workshop construction completed
Our company's key project in Shanxi Province in 2017-the construction of the API synthesis workshop was completed on November 6, 2017. Our company's API synthesis workshop officially started on April 1, 2017 and has now been completed. The workshop has a construction area of 2379.68 ㎡, a two-story reinforced concrete frame structure, and is equipped with 24 reactors of 3000L, 2000L, 1000L, 500L glass-lined and 316L stainless steel series. It is divided into a general production area and a Class D clean production area. It can carry out 5 unit reactions to complete (-15 ℃ -120 ℃) synthesis (including hydrogenation), filtration, centrifugation and dissolution.
隐藏域元素占位
2 PP ampoule varieties approved, can be put on the market within the year
After a long process of application and approval, good news came: our company's 2 PP ampoule varieties obtained production approval!
隐藏域元素占位
2016 Annual Work Summary and Commendation Conference Held in Datong Yungang International Hotel
On January 21, 2017, our company's 2016 work summary and commendation conference was solemnly held in Yungang International Hotel, Datong. The leaders of the former Chinese People's Liberation Army stationed in Tong82nd Brigade and the leaders of Nuocheng friendly units were invited to attend. Chairman Zhang Runcheng summarized the company's major achievements in 2016 and thanked all employees for their unremitting efforts. He said that after eight years of arduous and bloody struggle and hard work, Nuocheng finally won the three happiness: 1. The national exclusive product-non-PVC soft bag cimetidine sodium chloride injection was officially approved on December 26, 2016. 2. Merger
隐藏域元素占位
The Company Held 2014 Work Summary and Commendation Conference
The company held the 2014 work summary and commendation conference on the afternoon of February 7, 2015-072, and the company held the 2014 work summary and commendation conference ceremoniously. Invite relevant leaders, army chiefs and guests to gather together to celebrate the conference. At the conference, Chairman Zhang Runcheng made an annual work summary and fully affirmed the achievements of various production workshops and functional departments in the company's construction: on December 26, 1.2014, the signing ceremony of the "new third board" listing was held with Securities Co., Ltd. The listing of the "New Third Board" not only provides our company with new financing channels, but also introduces strategic investors to bring in capital.
隐藏域元素占位
Fuze the world, a promise will be made!
Norcheng Pharmaceuticals
Copyright©2023 Shanxi Nuocheng Pharmaceutical Co., Ltd.